GSK will buy Bellus Health for $2B, setting up showdown with Merck
GSK is dishing out $2 billion to acquire Bellus Health, the British pharma giant announced Tuesday morning, stoking more M&A buzz amid a widespread …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
